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Summary.-Extracts of glioblastomas and meningiomas were analysed by quantita-
tive immunoelectrophoresis for the presence of foetal brain antigens and tumour-
associated antigens, and levels of 2 normal brain-specific proteins were also deter-
mined. The following antibodies were used: monospecific anti-S-100 (glia specific);
monospecific anti-GFA (glial fibrillary acidic protein), (astroglia specific); poly-
specific anti-foetal brain (12-16th weekof gestation); a polyspecific anti-glioblastoma
antiserum, absorbed with insolubilized serum, haemolysate and normal brain
extract; polyspecific anti-meningioma antiserum, absorbed as for glioblastoma
antiserum; monospecific anti-a-foetoprotein; and monospecific anti-ferritin. Using
the antibodies raised against the tumours, several antigens not present in foetal or
adult normal brain were found in the glioblastomas and the meningiomas. These
antigens cross-reacted with antigens present in normal liver and were therefore not
tumour-associated. S-100 was found in glioblastomas in approximately one tenth
the amount in whole brain homogenate, whereas GFA was found 2-4 times enriched.
The 2 proteins were absent in meningiomas. The possible use of the GFA protein
as a marker for astroglial neoplasia is discussed.
Five foetal antigens were found in foetal brain, but none in the tumours.
a-Foetoprotein could only be demonstrated in foetal tissue extracts, including foetal
brain, but not in tumours. Ferritin was detected in all tumour extracts, althoughthe
amounts determined were unrelated to histological tumour type.
IN recent years, experiments have been
carried out to evaluate the immune
response to brain tumours in brain-
tumour patients (Levy, Mahalay and Day,
1972; Oda, 1974), but few immuno-
chemical investigations have been pub-
lished on the antigenic composition of
human brain tumours (Winters and Rich,
1975). The present study was under-
takento describe theantigenic composition
of the two most common intracranial
tumours (glioblastomas and meningiomas)
by use of quantitative immunoelectro-
phoretic methods (Axelsen, Kr0ll and
Weeke, 1973).
The presence orabsence ofneo-antigens
associated with the neoplastic trans-
formation was tested with different anti-
sera raised in rabbits by injection~s of
extracts of glioblastomas and meningio-
mas. The different tissue extracts were
further analysed, using antibodies against
foetal brain.
Analysis of two brain-specific antigens
was performed. The glial fibrillary acidic
protein (GFA) (Bignami et al., 1972) is
a protein located in the cytoplasm
of astroglial cells. S-100 (Hyden and
McEwen, 1966) is a protein predominantly
located in glial cells ofthe brain. Finally,
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the amounts of ferritin were determined,
and extracts were examined for the
presence ofa-foetoprotein.
MATERIALS AND METHODS
Collection of materials and extraction of
antigens.-During operations, about 1 g of
tissue was saved for immunochemical analy-
sis. Thesample was immediately transferred
to dry ice and stored at - 800C until analysis.
Then the tumour sample was thawed and cut
into pieces. One piece was sent for histo-
logical examination and the remainder was
placed, together with a small metal ball,
inside a nylon container fitting a Mikro-
dismembrator (B. Braun, Melsungen). The
nylon container was frozen in liquid N2 for
4-5min and placed in the dismembrator arm.
The frozen tissue was reduced to powder by
very fast movements of the metal ball inside
the nylon container, which was shaken by the
arm. The powder was suspended in the
extraction medium (5 ml/g wet weight).
The antigens were extracted with a medium
consisting of 2% v/v Triton X-100, 1 mM
EDTA, 15 mM NaN3, 12500 kiu/l of the
protease inhibitor Aprotinin (Trasylol ®,
Bayer) and 10 mM sodium barbital buffer
adjusted to pH 8-5. The suspension was
centrifuged at 180000 g for 45 min. This
procedure was used both for the preparation
of extracts for immunization of rabbits and
for immunochemical analysis. Protein con-
centrations were determined by the method
of Lowry et al. (1951), using bovine serum
albumin as standard. To all samples, 1: 10
amount of 2% w/v sodium dodecyl sulphate
solution was added before total protein
determination.
Normal brain was obtained from victims
of traffic accidents, the autopsy being per-
formed 8-10 h after death. Liver specimens
were obtained by biopsy during gastro-
intestinal operations. Foetal tissues were
obtained from abortions at the 12-16th week
of gestation and necropsied within 1 h of
abortion.
Antibodies.-A monospecific rabbit anti-
serum against human glial fibrillary acidic
protein (GFA) was raised against GFA
kindly supplied by Dr L. Eng, Palo Alto,
California, U.S.A. A specific rabbit anti-
serum against bovine S-100 protein was
kindlysuppliedbyDrK. G. Haglid, Goteborg,
Sweden. Polyspecific rabbit antisera were
raised against extracts of glioblastomas,
meningiomas and foetal brain (12-16th week
of gestation). Four rabbits were immunized
with glioblastoma extracts for 1 year. Three
different tumours of identical histology were
used to prepare antigens and after bleeding
the antisera were pooled. Three rabbits
were immunized with meningioma extracts
originating from 2 tumours. Immunization
with foetal brain was performed on 5 rabbits
for more than 1 year, using extracts of 3
foetal brains sequentially. The immuni-
zation protocol and the immunoglobulin
purification method were those of Harboe
and Ingild (1973).
An antiserum specific for human ferritin
was a gift from Dr B. G. Johansson, Lund,
Sweden.
Absorption of antisera was performed by
antigens covalently linked to Sepharose
using CNBr-activated Sepharose ® purchased
from Pharmacia, Uppsala, Sweden. One
hundred and fifty milligrammes protein was
coupled to 15 g Sepharose. To this, aliquots
of 100 ml antiserum were absorbed, and the
absorbed antibodies were eluted by 2 M
guanidinium HC1, pH 3 0, before another
application of antiserum. The efficiency of
the absorptions was tested by crossed IE of
the antigen preparations used for absorptions
against the absorbed antisera.
An antiserum specific for human cx-
foetoprotein was purchased from DAKO
Immunoglobulins A/S, Copenhagen, Den-
mark.
Quantitative immunoelectrophoresis (QIE).
-QIE (crossed IE, crossed-line IE and
rocket IE) was performed as described in the
manual by Axelsen, Kr0ll and Weeke (1973).
The agarose gels contained 022% Triton
X-100, in order to keep detergent-solubilized
membrane proteins in solution. GFA, S-100
and ferritin were estimated by rocket IE,
and expressed relative to total protein as per
cent of the content in an extract of whole
normal adult brain.
RESULTS
Samples from 20 tumour patients and
from2non-tumourpatients wereexamined.
A small slice of each sample was put into
formalin at the time of extraction. The
microscopic examination of this slice wasBRAIN TUMOUR ANTIGENS
taken as representative of the sample,
and was compared with the tissue sample
originally examined by the neuropatholo-
gist. Of 11 samples from operations for
glioblastomas, 7 slices were well preserved,
3 showed marked necrosis, and one con-
tained only white and grey matter with
gliosis, but no tumour tissue. Two sam-
ples from non-tumour operations showing
a well preserved gliosis were included in
the study. Three tumours were carcino-
matous metastases to the brain, all show-
ing histological signs of contamination
with adjacent brain. Six meningiomas
were examined. In this way 5 categories
were examined: 7 glioblastomas, 3 necrotic
glioblastomas, 3 samples of gliosis, 3
metastases and 6 meningiomas. No suit-
able astrocytoma lower than Grade IV
was found during the study. No tumour
of disputable histology was included in
the series.
Fig. 1 shows a crossed IE of foetal
brain extract against unabsorbed poly-
specific foetal brain antibodies. It was
shown by crossed-line IE experiments
that the foetal brain contained 5 foetal
antigens (dots in Fig. 1). After sequential
absorptions of the antiserum with in-
solubilized serum, haemolysate and adult
brain, antibodies against these antigens
were still present. In extracts of adult
brain, adult blood, foetal liver and foetal
blood, these antigens were not present.
Crossed-line IE used for this purpose is
able to detect foetal antigens present in
tissue extracts in amounts higher than
1-5% of the amount present in the
reference tissue (foetal brain). oc-Foeto-
protein in Fig. 1 was identified by crossed
IE with anti-a-foetoprotein in an inter-
mediate gel.
By crossed IE oftumour extracts or by
addition of tumour extracts to foetal
brain extract, it was not possible to
demonstrate any of the 5 foetal antigens
in any tumour extract.
Antisera against glioblastomas and
against meningiomas contained more than
25 precipitating antibodies, as deter-
mined by crossed IE of tumour extracts.
After absorption of the antisera with
FIG. 1.-Crossed immunoelectrophoresis (IE) of foetal brain extract (16th week of gestation) using
unabsorbed anti-foetal-brain antibodies in the second dimension gel. First dimension electro-
phoresis at 10 V/cm for 50 min with anode at the right. Second dimension electrophoresis at
2 V/cm overnight, anode at the top. Staining: Coomassie Brilliant Blue. The dots indicate 5
foetal antigens (HF 1-HF 5). AFP, a-foetoprotein. HSA, human serum albumin.
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adult serum, haemolysate, brain and liver,
all antibody activity was removed. All
the individual tumour extracts were sub-
mitted to crossed IE against both the 2
absorbed tumour antisera.
The results of the estimation of GFA,
S-100 and ferritin are shown in Figs. 2, 3
and 4. GFA is seen to be absent in
meningiomas, close to normal in gliosis
except in one case, increased 2-6 times on
Meningioma 161 '*
Brain tissue without tumour
but with reactive gliosis (3)
Glioblastoma (7) .
Necrotic glioblastoma (3)
Carcinoma metastasis (3)
0 100 ._200 300 4__ A.U.
FIG. 2.-Estimation of the GFA protein.
Number of samples in brackets. The con-
tent of GFA in a homogenate of whole
normal adult brain is taken as 100 AU.
Meningioma (6) S
Brain tissue without tumour
but with reactive gliosis (3) . *
Glioblastoma (7) lbe e *
Necrotic glioblastoma (3)
Carcinoma metastasis (3) .e
I.. i .. . I..
0 50 100
FIG. 3. Estimation of the S-100 protein.
Number of samples in brackets. The con-
tent of S-100 in a homogenate of whole
normal adult brain is taken as 100 AU.
Meningioma o 6) * *u* br o
sapesi rakt. Th!oteto
Br riin tissu i without tumour
but with reactive gliosist3)
Glioblastoma (7) * .* . . ..
Necrotic glioblastoma (3)
Carcinoma metastasis(2) * 4
0 25 50 75 100 A.U
FIG. 4.-Estimation of ferritin. Number of
samples in brackets. The content of
ferritin in a homogenate of whole normal
adult brain is taken as 100 AU.
average in glioblastomas, but decreased
in necrotic samples. S-100 was found in
rather low amounts except in gliosis.
Ferritin was detected in all extracts, al-
though the amounts determined were
unrelated to sample type. Analytical
standard deviation of the analyses of
these 3 proteins by QIE was found to be
10%.
GFA and S-100 in the glioblastomas
were immunochemically identical to the
normal adult GFA and S-100. GFA and
S-100 were also present in foetal brain
extract. Foetal S-100 was immuno-
chemically identical to the adult protein.
However, foetal GFA precipitates in a
reproducibly different manner than adult
GFA, indicating a physico-chemical dif-
ference (Fig. 5).
A.U.
FiG. 5.-Fused rocket immunoelectrophore-
sis of extracts of adult brain (a, 4 ,u con-
taining 9-2 ,cg protein) and foetal brain
(b, 20 ,zl containing 348 ,ug protein). Anti-
serum is anti-GFA antiserum, 2-5 MIl/cm2.
GFA in both extracts shows reaction of
immunochemical identity; however the
foetal GFA precipitate is more blurred
than the adult GFA precipitate, indicating
physico-chemical differences.BRAIN TUMOUR ANTIGENS
ax-Foetoprotein was not present in the
tumours, but only in foetal brain extract,
probably due to contamination with
foetal blood.
DISCUSSION
In spite of extensive experimental
work with polyspecific antisera, and the
sensitive and highly resolving QIE
methods, we were unable to find any
brain-tumour-associated antigen or any
onco-foetal brain antigen in human glio-
blastomas or meningiomas. This is con-
sistent with the reports ofHass (1966) and
Delpech et al. (1972) where the glioblas-
tomas are concerned, but inconsistent
with the meningioma study by Winters
and Rich (1975) and the studies by
Trouillas on glioblastomas (1971, 1972),
and other studies (Mahalay, Mahalay and
Day, 1965; Lim and Kluskens, 1972;
Wahlstrom et al., 1974). In the present
study, 5 foetal antigens were found in
foetal brain, but none ofthese were found
in the tumours. Our results therefore do
not confirm Trouillas' reports (Trouillas,
1971, 1972) on the existence of a human
carcino-foetal glial antigen. The reason
for the above-mentioned discrepancies is
probably that different techniques have
been used: Trouillas (1971, 1972) used
patients' antibodies after autochthonous
immunization instead of rabbit anti-
bodies.
In the present study rabbit antisera
against glioblastoma extracts and mening-
ioma extracts revealed antigens which
were apparently tumour-associated, since
they were not identical to any antigen
found in normal or in foetal brain. How-
ever, they were present in extract from
normal adult liver, indicating that the
antigens were normal tissue components.
Few reports have considered the im-
munochemical composition of meningio-
mas (Winters and Rich, 1975). The
results of our study do not confirm the
findings of meningioma-associated anti-
gens, but our extraction procedure was
different from that of Winters and Rich,
and therefore the findings are not directly
comparable.
Also, cellular immune reactions have
indicated the existence of human tumour-
associated antigens (Brooks et al., 1972;
Levy et al., 1972; Kumar et al., 1973;
Oda, 1974). In these studies the chemical
nature of the antigens was not investi-
gated, but they are usually presumed to be
membrane proteins. With the methods
used in the present study it has been
possible in normal brain extracts to
estimate membrane-bound brain antigens
(Bock et at., 1975) and therefore the con-
clusions of the present study also apply
to membrane antigens.
The presence of the S-100 antigen in
intracranial tumours has been investi-
gated before, and used in the discussion
of the histogenesis of different tumour
types (Pfeiffer et al., 1972). Haglid et al.
(1973) found a content of S-100 in low-
grade astrocytomas that equalled the
content in normal white matter; but in
glioblastomas they found a significantly
lower level, which is in accordance with
our data. The difference in the content
of S-100 in little or highly differentiated
astrocytomas reported by Haglid et al.
(1973) has been used for discussion of the
histopathological concept of dedifferentia-
tion, although it seems difficult to assess
the degree of maturation of a certain cell
type, only from knowledge of one protein
the function of which is still unclear.
Furthermore, the problems of relating
the amount of a specific protein to the
total volume occupied by the cell type to
which the protein is assumed to be
restricted have not at all been solved.
These problems comprise the hetero-
geneity of the brain cells, the differences
in water content, especially in pathological
cases, and the abundance of stromal
elements in the tumours.
The presence of the GFA protein in
astrocytomas has previously been demon-
strated by Uyeda, Eng and Bigami (1972)
by means of immunofluorescence micro-
scopy, but results ofestimation of GFA in
human tumours have not been published
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before. The average enrichment of GFA
in glioblastomas was, in the present study,
found to be 2 6 times that in normal
whole brain. This is, however, a high
estimate, due to our standard being
expressed relative to total protein of a
whole brain extract, and the tumours do
not represent grey matter, in which the
GFA is present in lower concentration
than in white matter. It seems justifiable
to say, from the present study, especially
when one compares meningiomas with
glioblastomas (Fig. 2), that the glioblasto-
mas have retained some ofthe biochemical
specificity of cells derived from the neural
tube. It is not possible to state whether
the content of GFA in the metastases
reflects a potentiality in the neoplastic
cells for synthesis of this protein, or
whether it is a measure of contamination
from adjacent brain. It is of interest
that the S-100 and GFA found in glio-
blastomas were immunochemically identi-
cal to the proteins of normal adult brain,
although GFA in foetal brain extracts
differed slightly with regard to precipitate
morphology from adult brain extracts
(cf. Fig. 5).
Besides the increased content of GFA
in tumours shown in the present study, an
increased amount of GFA has been found
in glial multiple sclerosis scars, from which
GFA was originally isolated (Eng et at.,
1971), in injured brain tissue (Bignami and
Dahl, 1974), and in short-term cultivated
glial cells (Bock et al., 1975). As GFA is
considered an astrocytic protein (Bignami
et al., 1972) the results on GFA indicate
that glioblastoma cells belong to the
astroglial series of tumours. As the con-
tent of GFA increases in circumstances
where the astroglial cells proliferate, it
seems worthwhile to investigate the pre-
sence of GFA in blood, urine and cerebro-
spinal fluid in different neurological dis-
eases, including neoplasia.
A comparison of the data obtained on
the individual tumour specimens did not
add substantially to the results of this
study, with one exception. In Fig. 6 the
GFA content of the glioblastomas, of the
GFA
A.U.
400 -
300
200-
100 -
10 30 SO 110 130A.U.
S-100
a BRAIN TISSUE WITHOUT TUMOUR BUT WITH REACTIVE
GLIOSIS
O GLIOBLASTOMA
O NECROTIC GLIOBLASTOMA
FIG. 6.-Diagram showing the relationship
between the content of GFA and S-100 for
three types of specimens. See text.
necrotic samples and of the reactive
gliosis is compared with the content of
S-100. As mentioned above, Haglid et at.
(1973) showed a tendency for decreasing
content of S-100 protein with increasing
malignancy of the tumours. Our results
come from only one type of glioma
(glioblastomas) and the results seem to
indicate the existence of a negative
correlation between GFA and S-100 in this
particular type of tumour. The results
stress the need for determining biochemi-
cal parameters for different histological
grades of tumour in order to give further
background for the grading.
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